サマリー

市場の分析と洞察。粘膜下注射剤の世界市場
COVID-19のパンデミックにより、粘膜下注射剤の世界市場規模は2021年に9535万米ドルの値を示し、2028年には1億5976万米ドルの再調整サイズとなり、予測期間2022-2028年にはCAGR7.65%になると予測されています。
世界の粘膜下注射剤の範囲と市場規模
粘膜下注入剤の世界市場は、地域（国）別、企業別、タイプ別、用途別に分類されています。粘膜下注射剤の世界市場におけるプレイヤー、ステークホルダー、その他の参加者は、本レポートを強力なリソースとして活用することで、優位に立つことが可能となります。セグメント別分析では、地域（国）別、タイプ別、アプリケーション別の売上高、収益、2017-2028年の予測に焦点を当てています。

企業別
セイカガク
オベスコ エンドスコピー
ジーアイサプライ
コスモファーマシューティカルズ
ボストン・サイエンティフィック
ザ・スタンダード
マイクロテック・エンドスコピー
エンドクロットプラス

包装形態別セグメント
シリンジタイプ
アンプルタイプ

用途別セグメント
病院
外来外科センター
専門クリニック

地域別
北米
米国
カナダ
メキシコ

アジア・パシフィック
中国
日本
韓国
インド
オーストラリア
東南アジア
その他のアジア太平洋地域
欧州
ドイツ
フランス
英国
イタリア
ロシア
スペイン
その他の欧州

中南米
ブラジル
アルゼンチン
コロンビア
ラテンアメリカの残りの部分

中近東・アフリカ
中東
アフリカ

ページTOPに戻る

目次

1 SUBMUCOSAL INJECTION AGENT MARKET OVERVIEW 1
1.1 SUBMUCOSAL INJECTION AGENT PRODUCT OVERVIEW 1
1.2 SUBMUCOSAL INJECTION AGENT MARKET SEGMENT BY TYPE 3
1.2.1 SYRINGE TYPE 3
1.2.2 AMPOULE TYPE 4
1.3 GLOBAL SUBMUCOSAL INJECTION AGENT MARKET SIZE BY TYPE 5
1.3.1 GLOBAL SUBMUCOSAL INJECTION AGENT MARKET SIZE OVERVIEW BY TYPE (2017-2028) 5
1.3.2 GLOBAL SUBMUCOSAL INJECTION AGENT HISTORIC MARKET SIZE REVIEW BY TYPE (2017-2022) 6
1.3.3 GLOBAL SUBMUCOSAL INJECTION AGENT FORECASTED MARKET SIZE BY TYPE (2023-2028) 7
1.4 KEY REGIONS MARKET SIZE SEGMENT BY TYPE 8
1.4.1 NORTH AMERICA SUBMUCOSAL INJECTION AGENT SALES BREAKDOWN BY TYPE (2017-2022) 8
1.4.2 EUROPE SUBMUCOSAL INJECTION AGENT SALES BREAKDOWN BY TYPE (2017-2022) 9
1.4.3 ASIA-PACIFIC SUBMUCOSAL INJECTION AGENT SALES BREAKDOWN BY TYPE (2017-2022) 10
1.4.4 LATIN AMERICA SUBMUCOSAL INJECTION AGENT SALES BREAKDOWN BY TYPE (2017-2022) 11
1.4.5 MIDDLE EAST AND AFRICA SUBMUCOSAL INJECTION AGENT SALES BREAKDOWN BY TYPE (2017-2022) 12
2 SUBMUCOSAL INJECTION AGENT MARKET COMPETITION BY COMPANY 14
2.1 GLOBAL TOP PLAYERS BY SUBMUCOSAL INJECTION AGENT SALES (2020-2022) 14
2.2 GLOBAL TOP PLAYERS BY SUBMUCOSAL INJECTION AGENT REVENUE (2020-2022) 15
2.3 GLOBAL TOP PLAYERS BY SUBMUCOSAL INJECTION AGENT PRICE (2020-2022) 16
2.4 GLOBAL TOP MANUFACTURERS SUBMUCOSAL INJECTION AGENT MANUFACTURING BASE DISTRIBUTION, SALES AREA 16
2.5 SUBMUCOSAL INJECTION AGENT MARKET COMPETITIVE SITUATION AND TRENDS 17
2.5.1 SUBMUCOSAL INJECTION AGENT MARKET CONCENTRATION RATE (2020-2022) 17
2.5.2 GLOBAL 3 AND 5 LARGEST MANUFACTURERS BY SUBMUCOSAL INJECTION AGENT REVENUE IN 2021 18
2.6 GLOBAL TOP MANUFACTURERS BY COMPANY TYPE (TIER 1, TIER 2, AND TIER 3) & (BASED ON THE REVENUE IN SUBMUCOSAL INJECTION AGENT AS OF 2021) 19
2.7 KEY MANUFACTURERS SUBMUCOSAL INJECTION AGENT PRODUCT OFFERED 19
3 SUBMUCOSAL INJECTION AGENT STATUS AND OUTLOOK BY REGION 21
3.1 GLOBAL SUBMUCOSAL INJECTION AGENT MARKET SIZE AND CAGR BY REGION: 2017 VS 2021 VS 2028 21
3.2 GLOBAL SUBMUCOSAL INJECTION AGENT HISTORIC MARKET SIZE BY REGION 21
3.2.1 GLOBAL SUBMUCOSAL INJECTION AGENT SALES IN VOLUME BY REGION (2017-2022) 21
3.2.2 GLOBAL SUBMUCOSAL INJECTION AGENT SALES IN VALUE BY REGION (2017-2022) 22
3.2.3 GLOBAL SUBMUCOSAL INJECTION AGENT SALES (VOLUME & VALUE), PRICE (2017-2022) 22
3.3 GLOBAL SUBMUCOSAL INJECTION AGENT FORECASTED MARKET SIZE BY REGION 23
3.3.1 GLOBAL SUBMUCOSAL INJECTION AGENT SALES IN VOLUME BY REGION (2023-2028) 23
3.3.2 GLOBAL SUBMUCOSAL INJECTION AGENT SALES IN VALUE BY REGION (2023-2028) 23
3.3.3 GLOBAL SUBMUCOSAL INJECTION AGENT SALES (VOLUME & VALUE), PRICE (2023-2028) 24
4 SUBMUCOSAL INJECTION AGENT BY APPLICATION 25
4.1 GLOBAL SUBMUCOSAL INJECTION AGENT MARKET SIZE BY APPLICATION 25
4.1.1 GLOBAL SUBMUCOSAL INJECTION AGENT MARKET SIZE OVERVIEW BY APPLICATION (2017-2028) 25
4.1.2 GLOBAL SUBMUCOSAL INJECTION AGENT HISTORIC MARKET SIZE REVIEW BY APPLICATION (2017-2022) 26
4.1.3 GLOBAL SUBMUCOSAL INJECTION AGENT FORECASTED MARKET SIZE BY APPLICATION (2023-2028) 27
4.2 KEY REGIONS MARKET SIZE SEGMENT BY APPLICATION 28
4.2.1 NORTH AMERICA SUBMUCOSAL INJECTION AGENT SALES BREAKDOWN BY APPLICATION (2017-2022) 28
4.2.2 EUROPE SUBMUCOSAL INJECTION AGENT SALES BREAKDOWN BY APPLICATION (2017-2022) 29
4.2.3 ASIA-PACIFIC SUBMUCOSAL INJECTION AGENT SALES BREAKDOWN BY APPLICATION (2017-2022) 30
4.2.4 LATIN AMERICA SUBMUCOSAL INJECTION AGENT SALES BREAKDOWN BY APPLICATION (2017-2022) 31
4.2.5 MIDDLE EAST AND AFRICA SUBMUCOSAL INJECTION AGENT SALES BREAKDOWN BY APPLICATION (2017-2022) 32
5 NORTH AMERICA SUBMUCOSAL INJECTION AGENT BY COUNTRY 34
5.1 NORTH AMERICA SUBMUCOSAL INJECTION AGENT HISTORIC MARKET SIZE BY COUNTRY 34
5.1.1 NORTH AMERICA SUBMUCOSAL INJECTION AGENT SALES IN VOLUME BY COUNTRY (2017-2022) 34
5.1.2 NORTH AMERICA SUBMUCOSAL INJECTION AGENT SALES IN VALUE BY COUNTRY (2017-2022) 34
5.2 NORTH AMERICA SUBMUCOSAL INJECTION AGENT FORECASTED MARKET SIZE BY COUNTRY 35
5.2.1 NORTH AMERICA SUBMUCOSAL INJECTION AGENT SALES IN VOLUME BY COUNTRY (2023-2028) 35
5.2.2 NORTH AMERICA SUBMUCOSAL INJECTION AGENT SALES IN VALUE BY COUNTRY (2023-2028) 35
6 EUROPE SUBMUCOSAL INJECTION AGENT BY COUNTRY 36
6.1 EUROPE SUBMUCOSAL INJECTION AGENT HISTORIC MARKET SIZE BY COUNTRY 36
6.1.1 EUROPE SUBMUCOSAL INJECTION AGENT SALES IN VOLUME BY COUNTRY (2017-2022) 36
6.1.2 EUROPE SUBMUCOSAL INJECTION AGENT SALES IN VALUE BY COUNTRY (2017-2022) 36
6.2 EUROPE SUBMUCOSAL INJECTION AGENT FORECASTED MARKET SIZE BY COUNTRY 37
6.2.1 EUROPE SUBMUCOSAL INJECTION AGENT SALES IN VOLUME BY COUNTRY (2023-2028) 37
6.2.2 EUROPE SUBMUCOSAL INJECTION AGENT SALES IN VALUE BY COUNTRY (2023-2028) 38
7 ASIA-PACIFIC SUBMUCOSAL INJECTION AGENT BY REGION 39
7.1 ASIA-PACIFIC SUBMUCOSAL INJECTION AGENT HISTORIC MARKET SIZE BY REGION 39
7.1.1 ASIA-PACIFIC SUBMUCOSAL INJECTION AGENT SALES IN VOLUME BY REGION (2017-2022) 39
7.1.2 ASIA-PACIFIC SUBMUCOSAL INJECTION AGENT SALES IN VALUE BY REGION (2017-2022) 39
7.2 ASIA-PACIFIC SUBMUCOSAL INJECTION AGENT FORECASTED MARKET SIZE BY REGION 40
7.2.1 ASIA-PACIFIC SUBMUCOSAL INJECTION AGENT SALES IN VOLUME BY REGION (2023-2028) 40
7.2.2 ASIA-PACIFIC SUBMUCOSAL INJECTION AGENT SALES IN VALUE BY REGION (2023-2028) 41
8 LATIN AMERICA SUBMUCOSAL INJECTION AGENT BY COUNTRY 42
8.1 LATIN AMERICA SUBMUCOSAL INJECTION AGENT HISTORIC MARKET SIZE BY COUNTRY 42
8.1.1 LATIN AMERICA SUBMUCOSAL INJECTION AGENT SALES IN VOLUME BY COUNTRY (2017-2022) 42
8.1.2 LATIN AMERICA SUBMUCOSAL INJECTION AGENT SALES IN VALUE BY COUNTRY (2017-2022) 42
8.2 LATIN AMERICA SUBMUCOSAL INJECTION AGENT FORECASTED MARKET SIZE BY COUNTRY 43
8.2.1 LATIN AMERICA SUBMUCOSAL INJECTION AGENT SALES IN VOLUME BY COUNTRY (2023-2028) 43
8.2.2 LATIN AMERICA SUBMUCOSAL INJECTION AGENT SALES IN VALUE BY COUNTRY (2023-2028) 43
9 MIDDLE EAST AND AFRICA SUBMUCOSAL INJECTION AGENT BY COUNTRY 44
9.1 MIDDLE EAST AND AFRICA SUBMUCOSAL INJECTION AGENT HISTORIC MARKET SIZE BY COUNTRY 44
9.1.1 MIDDLE EAST AND AFRICA SUBMUCOSAL INJECTION AGENT SALES IN VOLUME BY COUNTRY (2017-2022) 44
9.1.2 MIDDLE EAST AND AFRICA SUBMUCOSAL INJECTION AGENT SALES IN VALUE BY COUNTRY (2017-2022) 44
9.2 MIDDLE EAST AND AFRICA SUBMUCOSAL INJECTION AGENT FORECASTED MARKET SIZE BY COUNTRY 45
9.2.1 MIDDLE EAST AND AFRICA SUBMUCOSAL INJECTION AGENT SALES IN VOLUME BY COUNTRY (2023-2028) 45
9.2.2 MIDDLE EAST AND AFRICA SUBMUCOSAL INJECTION AGENT SALES IN VALUE BY COUNTRY (2023-2028) 45
10 COMPANY PROFILES AND KEY FIGURES IN SUBMUCOSAL INJECTION AGENT BUSINESS 46
10.1 SEIKAGAKU 46
10.1.1 SEIKAGAKU CORPORATION INFORMATION 46
10.1.2 SEIKAGAKU INTRODUCTION AND BUSINESS OVERVIEW 46
10.1.3 SEIKAGAKU SUBMUCOSAL INJECTION AGENT SALES, REVENUE AND GROSS MARGIN (2020-2022) 46
10.1.4 SEIKAGAKU SUBMUCOSAL INJECTION AGENT PRODUCTS OFFERED 47
10.2 OVESCO ENDOSCOPY 47
10.2.1 OVESCO ENDOSCOPY CORPORATION INFORMATION 47
10.2.2 OVESCO ENDOSCOPY INTRODUCTION AND BUSINESS OVERVIEW 48
10.2.3 OVESCO ENDOSCOPY SUBMUCOSAL INJECTION AGENT SALES, REVENUE AND GROSS MARGIN (2020-2022) 48
10.2.4 OVESCO ENDOSCOPY SUBMUCOSAL INJECTION AGENT PRODUCTS OFFERED 48
10.3 GI SUPPLY 49
10.3.1 GI SUPPLY CORPORATION INFORMATION 49
10.3.2 GI SUPPLY INTRODUCTION AND BUSINESS OVERVIEW 49
10.3.3 GI SUPPLY SUBMUCOSAL INJECTION AGENT SALES, REVENUE AND GROSS MARGIN (2020-2022) 50
10.3.4 GI SUPPLY SUBMUCOSAL INJECTION AGENT PRODUCTS OFFERED 50
10.4 COSMO PHARMACEUTICALS 50
10.4.1 COSMO PHARMACEUTICALS CORPORATION INFORMATION 50
10.4.2 COSMO PHARMACEUTICALS INTRODUCTION AND BUSINESS OVERVIEW 51
10.4.3 COSMO PHARMACEUTICALS SUBMUCOSAL INJECTION AGENT SALES, REVENUE AND GROSS MARGIN (2020-2022) 51
10.4.4 COSMO PHARMACEUTICALS SUBMUCOSAL INJECTION AGENT PRODUCTS OFFERED 52
10.5 BOSTON SCIENTIFIC 52
10.5.1 BOSTON SCIENTIFIC CORPORATION INFORMATION 52
10.5.2 BOSTON SCIENTIFIC INTRODUCTION AND BUSINESS OVERVIEW 52
10.5.3 BOSTON SCIENTIFIC SUBMUCOSAL INJECTION AGENT SALES, REVENUE AND GROSS MARGIN (2020-2022) 53
10.5.4 BOSTON SCIENTIFIC SUBMUCOSAL INJECTION AGENT PRODUCTS OFFERED 53
10.6 THE STANDARD 54
10.6.1 THE STANDARD CORPORATION INFORMATION 54
10.6.2 THE STANDARD INTRODUCTION AND BUSINESS OVERVIEW 54
10.6.3 THE STANDARD SUBMUCOSAL INJECTION AGENT SALES, REVENUE AND GROSS MARGIN (2020-2022) 54
10.6.4 THE STANDARD SUBMUCOSAL INJECTION AGENT PRODUCTS OFFERED 54
10.7 MICRO-TECH ENDOSCOPY 55
10.7.1 MICRO-TECH ENDOSCOPY CORPORATION INFORMATION 55
10.7.2 MICRO-TECH ENDOSCOPY INTRODUCTION AND BUSINESS OVERVIEW 55
10.7.3 MICRO-TECH ENDOSCOPY SUBMUCOSAL INJECTION AGENT SALES, REVENUE AND GROSS MARGIN (2020-2022) 56
10.7.4 MICRO-TECH ENDOSCOPY SUBMUCOSAL INJECTION AGENT PRODUCTS OFFERED 56
10.8 ENDOCLOT PLUS 57
10.8.1 ENDOCLOT PLUS CORPORATION INFORMATION 57
10.8.2 ENDOCLOT PLUS INTRODUCTION AND BUSINESS OVERVIEW 57
10.8.3 ENDOCLOT PLUS SUBMUCOSAL INJECTION AGENT SALES, REVENUE AND GROSS MARGIN (2020-2022) 57
10.8.4 ENDOCLOT PLUS SUBMUCOSAL INJECTION AGENT PRODUCTS OFFERED 58
11 UPSTREAM, OPPORTUNITIES, CHALLENGES, RISKS AND INFLUENCES FACTORS ANALYSIS 59
11.1 SUBMUCOSAL INJECTION AGENT KEY RAW MATERIALS 59
11.1.1 KEY RAW MATERIALS 59
11.1.2 RAW MATERIALS KEY SUPPLIERS 60
11.2 MANUFACTURING COST STRUCTURE 61
11.2.1 RAW MATERIALS 61
11.2.2 LABOR COST 61
11.2.3 MANUFACTURING EXPENSES 61
11.3 SUBMUCOSAL INJECTION AGENT INDUSTRIAL CHAIN ANALYSIS 62
11.4 SUBMUCOSAL INJECTION AGENT MARKET DYNAMICS 62
11.4.1 SUBMUCOSAL INJECTION AGENT INDUSTRY TRENDS 62
11.4.2 SUBMUCOSAL INJECTION AGENT MARKET DRIVERS 63
11.4.3 SUBMUCOSAL INJECTION AGENT MARKET CHALLENGES 64
12 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS 65
12.1 SALES CHANNEL 65
12.2 SUBMUCOSAL INJECTION AGENT DISTRIBUTORS 66
12.3 SUBMUCOSAL INJECTION AGENT DOWNSTREAM CUSTOMERS 67
13 RESEARCH FINDINGS AND CONCLUSION 68
14 APPENDIX 69
14.1 RESEARCH METHODOLOGY 69
14.1.1 METHODOLOGY/RESEARCH APPROACH 69
14.1.2 DATA SOURCE 72
14.2 AUTHOR DETAILS 75
14.3 DISCLAIMER 75